332 related articles for article (PubMed ID: 15497826)
1. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant.
Clara M; Strenn B; Ausserleitner M; Kreuzinger N
Water Sci Technol; 2004; 50(5):29-36. PubMed ID: 15497826
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
Strenn B; Clara M; Gans O; Kreuzinger N
Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
[TBL] [Abstract][Full Text] [Related]
3. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.
Clara M; Strenn B; Gans O; Martinez E; Kreuzinger N; Kroiss H
Water Res; 2005 Nov; 39(19):4797-807. PubMed ID: 16242170
[TBL] [Abstract][Full Text] [Related]
4. The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants.
Clara M; Kreuzinger N; Strenn B; Gans O; Kroiss H
Water Res; 2005 Jan; 39(1):97-106. PubMed ID: 15607169
[TBL] [Abstract][Full Text] [Related]
5. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
7. Behaviour of pharmaceuticals and personal care products in a sewage treatment plant of northwest Spain.
Carballa M; Omil F; Lema JM; Llompart M; García C; Rodriguez I; Gómez M; Ternes T
Water Sci Technol; 2005; 52(8):29-35. PubMed ID: 16312948
[TBL] [Abstract][Full Text] [Related]
8. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
Kreuzinger N; Clara M; Strenn B; Kroiss H
Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the removal of phthalates and other organic pollutants from industrial wastewaters in membrane bioreactor and conventional activated sludge treatment plants.
Llop A; Borrull F; Pocurull E
Water Sci Technol; 2009; 60(9):2425-37. PubMed ID: 19901476
[TBL] [Abstract][Full Text] [Related]
10. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
11. The application of membrane bioreactors as decentralised systems for removal of endocrine disrupting chemicals and pharmaceuticals.
Le-Minh N; Coleman HM; Khan SJ; van Luer Y; Trang TT; Watkins G; Stuetz RM
Water Sci Technol; 2010; 61(5):1081-8. PubMed ID: 20220228
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration.
Clara M; Strenn B; Kreuzinger N
Water Res; 2004 Feb; 38(4):947-54. PubMed ID: 14769414
[TBL] [Abstract][Full Text] [Related]
13. Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment.
De Wever H; Weiss S; Reemtsma T; Vereecken J; Müller J; Knepper T; Rörden O; Gonzalez S; Barcelo D; Dolores Hernando M
Water Res; 2007 Feb; 41(4):935-45. PubMed ID: 17207834
[TBL] [Abstract][Full Text] [Related]
14. Comparison of linear alkylbenzene sulfonates removal in conventional activated sludge systems and membrane bioreactors.
De Wever H; Van Roy S; Dotremont C; Miller J; Knepper T
Water Sci Technol; 2004; 50(5):219-25. PubMed ID: 15497851
[TBL] [Abstract][Full Text] [Related]
15. Removal of a broad range of surfactants from municipal wastewater--comparison between membrane bioreactor and conventional activated sludge treatment.
González S; Petrovic M; Barceló D
Chemosphere; 2007 Feb; 67(2):335-43. PubMed ID: 17123581
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sludge characteristics and performance of a submerged membrane bioreactor and an activated sludge process at high solids retention time.
Massé A; Spérandio M; Cabassud C
Water Res; 2006 Jul; 40(12):2405-15. PubMed ID: 16759682
[TBL] [Abstract][Full Text] [Related]
17. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
Kimura K; Iwase T; Kita S; Watanabe Y
Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
[TBL] [Abstract][Full Text] [Related]
18. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor.
Quintana JB; Weiss S; Reemtsma T
Water Res; 2005 Jul; 39(12):2654-64. PubMed ID: 15979124
[TBL] [Abstract][Full Text] [Related]
19. Environmental assessment of anaerobically digested sludge reuse in agriculture: potential impacts of emerging micropollutants.
Hospido A; Carballa M; Moreira M; Omil F; Lema JM; Feijoo G
Water Res; 2010 May; 44(10):3225-33. PubMed ID: 20347114
[TBL] [Abstract][Full Text] [Related]
20. Determination of polycyclic musks in sewage sludge from Guangdong, China using GC-EI-MS.
Zeng X; Sheng G; Xiong Y; Fu J
Chemosphere; 2005 Aug; 60(6):817-23. PubMed ID: 15936801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
